Wen Jen Hwu

525 total citations
8 papers, 388 citations indexed

About

Wen Jen Hwu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Wen Jen Hwu has authored 8 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Wen Jen Hwu's work include Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (2 papers) and Colorectal and Anal Carcinomas (2 papers). Wen Jen Hwu is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), vaccines and immunoinformatics approaches (2 papers) and Colorectal and Anal Carcinomas (2 papers). Wen Jen Hwu collaborates with scholars based in United States and Australia. Wen Jen Hwu's co-authors include Martin R. Weiser, Jinru Shia, Jen Jen Yeh, Klaus J. Busam, Paul B. Chapman, Philip O. Livingston, Linda Williams, José G. Guillem, Daniel G. Coit and W. Douglas Wong and has published in prestigious journals such as Cancer Research, Annals of Surgery and The Lancet Oncology.

In The Last Decade

Wen Jen Hwu

8 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wen Jen Hwu United States	6	238	178	155	90	76	8	388
Hiroki Shomura Japan	12	264 1.1×	299 1.7×	211 1.4×	37 0.4×	27 0.4×	32	455
Kohji Nagata Japan	7	422 1.8×	71 0.4×	291 1.9×	285 3.2×	124 1.6×	10	569
Teppei Yamada Japan	11	239 1.0×	164 0.9×	81 0.5×	38 0.4×	59 0.8×	28	364
Lorenz Jost Switzerland	8	142 0.6×	99 0.6×	79 0.5×	49 0.5×	19 0.3×	11	342
Mary Beard United States	9	265 1.1×	130 0.7×	141 0.9×	78 0.9×	18 0.2×	9	418
John Joseph Wright United States	8	141 0.6×	89 0.5×	72 0.5×	80 0.9×	30 0.4×	31	312
Hans Anton Schloesser Germany	5	247 1.0×	168 0.9×	136 0.9×	33 0.4×	23 0.3×	11	438
Marya Chaney United States	11	348 1.5×	223 1.3×	104 0.7×	73 0.8×	59 0.8×	59	501
Ming Gu China	7	250 1.1×	206 1.2×	84 0.5×	43 0.5×	20 0.3×	12	381
Sheri McMahon United States	10	347 1.5×	299 1.7×	108 0.7×	30 0.3×	19 0.3×	31	478

Countries citing papers authored by Wen Jen Hwu

Since Specialization

Citations

This map shows the geographic impact of Wen Jen Hwu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Jen Hwu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Jen Hwu more than expected).

Fields of papers citing papers by Wen Jen Hwu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Jen Hwu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Jen Hwu. The network helps show where Wen Jen Hwu may publish in the future.

Co-authorship network of co-authors of Wen Jen Hwu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Jen Hwu. A scholar is included among the top collaborators of Wen Jen Hwu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Jen Hwu. Wen Jen Hwu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Trinh, Van Anh, et al.. (2018). Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma -- a clinical update.. PubMed. 25(135). 31–40. 2 indexed citations

2.

Vence, Luis M., Richard E. Royal, Janice N. Cormier, et al.. (2018). Abstract 614: Resiquimod, a Toll-like receptor agonist promotes melanoma regression by enhancing plasmacytoid dendritic cells and T cytotoxic activity as a vaccination adjuvant and by direct tumor application. Cancer Research. 78(13_Supplement). 614–614. 4 indexed citations

3.

Yeh, Jen Jen, Jinru Shia, Wen Jen Hwu, et al.. (2006). The Role of Abdominoperineal Resection as Surgical Therapy for Anorectal Melanoma. Annals of Surgery. 244(6). 1012–1017. 131 indexed citations

4.

Yeh, Jen Jen, Martin R. Weiser, Jinru Shia, & Wen Jen Hwu. (2005). Response of stage IV anal mucosal melanoma to chemotherapy. The Lancet Oncology. 6(6). 438–439. 30 indexed citations

5.

Ragupathi, Govind, Philip O. Livingston, Chandra Hood, et al.. (2003). Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.. PubMed. 9(14). 5214–20. 89 indexed citations

6.

Lohmann, Christina, Wen Jen Hwu, Kristin Iversen, Achim A. Jungbluth, & Klaus J. Busam. (2003). Primary malignant melanoma of the oesophagus. Melanoma Research. 13(6). 595–601. 28 indexed citations

7.

Klimek, Virginia M., Katherine S. Panageas, Cristina Musselli, et al.. (2002). T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants.. PubMed. 8(5). 967–72. 87 indexed citations

8.

Hwu, Wen Jen, Ronald R. Salem, Jeffrey Pollak, et al.. (1999). A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors.. PubMed. 11(11-12). 529–37. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact